drugset / Trial / NCT02242799

Dolutegravir Interactions With Artemisinin-based Combination Therapies

NCT02242799

RandomizedParallel-groupOpen-labelTreatment

Summary

Malaria and HIV are found in the same regions of the world and developing countries are most affected by both diseases. For malaria, new drugs have been introduced called ACTs. These drugs are effective against malaria but little is known about how the levels of these drugs in blood relate to how effective these drugs are. For HIV, a new drug has been developed called dolutegravir which has potential to be widely used in developing countries. This proposal will explore how dolutegravir affects the drug levels of these antimalarial drugs and vice versa. In total, 46 healthy volunteers will participate in this study.

Timeline

Start
2015-06
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Artemether Small molecule
Subject Artesunate Small molecule
Subject Dolutegravir Other / unclassified 50 mg
Subject amodiaquine Other / unclassified
Subject lumefantrine Small molecule